Contact
Please use this form to send email to PR contact of this press release:
KemPharm Announces Pricing of $50 Million Public Offering of Common Stock and Warrants and Uplisting to The Nasdaq Capital Market
TO:
Please use this form to send email to PR contact of this press release:
KemPharm Announces Pricing of $50 Million Public Offering of Common Stock and Warrants and Uplisting to The Nasdaq Capital Market
TO: